Stephen A. Hill's most recent trade in Lipocine Inc was a trade of 7,500 Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 12,750 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 7,500 | - | - | Restricted Stock Unit |